Establishment Labs Holdings Inc. Selling, General and Administrative Expense
Establishment Labs Holdings Inc. (ESTA) reported Selling, General and Administrative Expense of $46.91 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-08-07
- Establishment Labs Holdings Inc. selling, general and administrative expense for the quarter ending 2026-06-30 was $46.91M, a 6.18% increase year-over-year.
- Establishment Labs Holdings Inc. selling, general and administrative expense for the quarter ending 2026-03-31 was $43.60M, a 9.84% increase year-over-year.
- Establishment Labs Holdings Inc. selling, general and administrative expense for the quarter ending 2025-12-31 was $44.03M, a 0.02% increase year-over-year.
- Establishment Labs Holdings Inc. selling, general and administrative expense for the quarter ending 2025-09-30 was $37.17M, a 9.14% increase year-over-year.
- Establishment Labs Holdings Inc. selling, general and administrative expense for fiscal 2025 was $165.07M, a 18.07% increase from fiscal 2024.
- Establishment Labs Holdings Inc. selling, general and administrative expense for fiscal 2024 was $139.81M, a 3.96% decline from fiscal 2023.
- Establishment Labs Holdings Inc. selling, general and administrative expense for fiscal 2023 was $145.57M, a 15.55% increase from fiscal 2022.
- Establishment Labs Holdings Inc. selling, general and administrative expense for fiscal 2022 was $125.98M, a 36.60% increase from fiscal 2021.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $46.91M 10-Q · filed 2026-08-07 | $90.51M 10-Q · filed 2026-08-07 | $134.54M derived: sum of 3 quarters · filed 2026-08-07 | $171.70M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $43.60M 10-Q · filed 2026-05-08 | $87.63M derived: sum of 2 quarters · filed 2026-05-08 | $124.80M derived: sum of 3 quarters · filed 2026-05-08 | $168.97M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $44.03M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $81.19M derived: sum of 2 quarters · filed 2026-02-27 | $125.37M derived: sum of 3 quarters · filed 2026-08-07 | $165.07M 10-K · filed 2026-02-27 |
| 2025-09-30 | $37.17M 10-Q · filed 2025-11-07 | $81.34M derived: sum of 2 quarters · filed 2026-08-07 | $121.04M 10-Q · filed 2025-11-07 | $165.06M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $44.18M 10-Q · filed 2026-08-07 | $83.88M 10-Q · filed 2026-08-07 | $127.89M derived: sum of 3 quarters · filed 2026-08-07 | $161.95M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $39.70M 10-Q · filed 2026-05-08 | $83.72M derived: sum of 2 quarters · filed 2026-05-08 | $117.77M derived: sum of 3 quarters · filed 2026-05-08 | $150.56M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $44.02M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $78.07M derived: sum of 2 quarters · filed 2026-02-27 | $110.86M derived: sum of 3 quarters · filed 2026-02-27 | $139.81M 10-K · filed 2026-02-27 |
| 2024-09-30 | $34.05M 10-Q · filed 2025-11-07 | $66.85M derived: sum of 2 quarters · filed 2025-11-07 | $95.79M 10-Q · filed 2025-11-07 | $132.67M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $32.79M 10-Q · filed 2025-08-07 | $61.73M 10-Q · filed 2025-08-07 | $98.61M derived: sum of 3 quarters · filed 2026-02-27 | $138.57M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $28.94M 10-Q · filed 2025-05-09 | $65.82M derived: sum of 2 quarters · filed 2026-02-27 | $105.78M derived: sum of 3 quarters · filed 2026-02-27 | $142.81M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $36.88M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $76.84M derived: sum of 2 quarters · filed 2026-02-27 | $113.87M derived: sum of 3 quarters · filed 2026-02-27 | $145.57M 10-K · filed 2026-02-27 |
| 2023-09-30 | $39.96M 10-Q · filed 2024-11-12 | $76.99M derived: sum of 2 quarters · filed 2024-11-12 | $108.69M 10-Q · filed 2024-11-12 | $143.54M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $37.03M 10-Q · filed 2024-08-07 | $68.73M 10-Q · filed 2024-08-07 | $103.58M derived: sum of 3 quarters · filed 2025-02-28 | $134.85M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $31.71M 10-Q · filed 2024-05-09 | $66.55M derived: sum of 2 quarters · filed 2025-02-28 | $97.82M derived: sum of 3 quarters · filed 2025-02-28 | $130.78M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $34.85M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $66.11M derived: sum of 2 quarters · filed 2025-02-28 | $99.07M derived: sum of 3 quarters · filed 2025-02-28 | $125.98M 10-K · filed 2025-02-28 |
| 2022-09-30 | $31.27M 10-Q · filed 2023-11-08 | $64.22M derived: sum of 2 quarters · filed 2023-11-08 | $91.14M 10-Q · filed 2023-11-08 | $118.70M derived: sum of 4 quarters · filed 2024-03-04 |
| 2022-06-30 | $32.96M 10-Q · filed 2023-08-09 | $59.87M 10-Q · filed 2023-08-09 | $87.43M derived: sum of 3 quarters · filed 2024-03-04 | $112.21M derived: sum of 4 quarters · filed 2024-03-04 |
| 2022-03-31 | $26.91M 10-Q · filed 2023-05-10 | $54.47M derived: sum of 2 quarters · filed 2024-03-04 | $79.25M derived: sum of 3 quarters · filed 2024-03-04 | $101.00M derived: sum of 4 quarters · filed 2024-03-04 |
| 2021-12-31 | $27.56M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-04 | $52.34M derived: sum of 2 quarters · filed 2024-03-04 | $74.09M derived: sum of 3 quarters · filed 2024-03-04 | $92.23M 10-K · filed 2024-03-04 |
| 2021-09-30 | $24.78M 10-Q · filed 2022-11-09 | $46.53M derived: sum of 2 quarters · filed 2022-11-09 | $64.67M 10-Q · filed 2022-11-09 | $82.87M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $21.75M 10-Q · filed 2022-08-09 | $39.89M 10-Q · filed 2022-08-09 | $58.09M derived: sum of 3 quarters · filed 2023-03-01 | $73.09M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $18.14M 10-Q · filed 2022-05-10 | $36.33M derived: sum of 2 quarters · filed 2023-03-01 | $51.34M derived: sum of 3 quarters · filed 2023-03-01 | $65.78M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $18.20M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $33.20M derived: sum of 2 quarters · filed 2023-03-01 | $47.64M derived: sum of 3 quarters · filed 2023-03-01 | $66.63M 10-K · filed 2023-03-01 |
| 2020-09-30 | $15.01M 10-Q · filed 2021-11-09 | $29.45M derived: sum of 2 quarters · filed 2021-11-09 | $48.43M 10-Q · filed 2021-11-09 | $65.56M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $14.44M 10-Q · filed 2021-07-30 | $33.42M 10-Q · filed 2021-07-30 | $50.56M derived: sum of 3 quarters · filed 2022-03-01 | $69.78M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $18.98M 10-Q · filed 2021-05-06 | $36.12M derived: sum of 2 quarters · filed 2022-03-01 | $55.34M derived: sum of 3 quarters · filed 2022-03-01 | $73.74M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $17.13M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $36.36M derived: sum of 2 quarters · filed 2022-03-01 | $54.76M derived: sum of 3 quarters · filed 2022-03-01 | $70.81M 10-K · filed 2022-03-01 |
| 2019-09-30 | $19.23M 10-Q · filed 2020-11-09 | $37.62M derived: sum of 2 quarters · filed 2020-11-09 | $53.68M 10-Q · filed 2020-11-09 | $68.51M derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | $18.39M 10-Q · filed 2020-08-07 | $34.45M 10-Q · filed 2020-08-07 | $49.28M derived: sum of 3 quarters · filed 2020-08-07 | $62.27M derived: sum of 4 quarters · filed 2020-08-07 |
| 2019-03-31 | $16.06M 10-Q · filed 2020-05-08 | $30.89M derived: sum of 2 quarters · filed 2020-05-08 | $43.87M derived: sum of 3 quarters · filed 2020-05-08 | $54.70M derived: sum of 4 quarters · filed 2020-05-08 |
| 2018-12-31 | $14.83M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $27.82M derived: sum of 2 quarters · filed 2020-03-16 | $38.65M derived: sum of 3 quarters · filed 2020-03-16 | $47.30M 10-K · filed 2020-03-16 |
| 2018-09-30 | $12.98M 10-Q · filed 2019-11-12 | $23.81M derived: sum of 2 quarters · filed 2019-11-12 | $32.46M 10-Q · filed 2019-11-12 | $41.17M derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | $10.83M 10-Q · filed 2019-08-13 | $19.48M 10-Q · filed 2019-08-13 | $28.18M derived: sum of 3 quarters · filed 2019-08-13 | $36.32M derived: sum of 4 quarters · filed 2019-08-13 |
| 2018-03-31 | $8.65M 10-Q · filed 2019-05-15 | $17.36M derived: sum of 2 quarters · filed 2019-05-15 | $25.49M derived: sum of 3 quarters · filed 2019-05-15 | $33.62M derived: sum of 4 quarters · filed 2019-05-15 |
| 2017-12-31 | $8.71M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-20 | $16.85M derived: sum of 2 quarters · filed 2019-03-20 | $24.97M derived: sum of 3 quarters · filed 2019-03-20 | $30.82M 10-K · filed 2019-03-20 |
| 2017-09-30 | $8.14M 10-Q · filed 2018-11-13 | $16.27M derived: sum of 2 quarters · filed 2018-11-13 | $22.11M 10-Q · filed 2018-11-13 | |
| 2017-06-30 | $8.13M 10-Q · filed 2018-09-13 | $13.97M 10-Q · filed 2018-09-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |